Ascertainment Bias in TB Treatment Trials: Can Systematic Assessment of Objective Endpoints Solve It?
Am J Respir Crit Care Med
.
2023 May 15;207(10):1269-1270.
doi: 10.1164/rccm.202303-0430ED.
Authors
Carole D Mitnick
1
,
Andrew J Nunn
2
Affiliations
1
Department of Global Health and Social Medicine Harvard Medical School Boston, Massachusetts.
2
Medical Research Council Clinical Trials Unit at UCL University College London London, United Kingdom.
PMID:
36952239
PMCID:
PMC10595440
DOI:
10.1164/rccm.202303-0430ED
No abstract available
Publication types
Editorial
Comment
MeSH terms
Bias
Humans
Tuberculosis* / drug therapy
Grants and funding
MC_UU_00004/04/MRC_/Medical Research Council/United Kingdom
MC_UU_12023/27/MRC_/Medical Research Council/United Kingdom